日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Negative Feedback of the Glutamine/Prostatitis Loop Identified Among 1400 Metabolites and Prostatitis via Mendelian Randomization

通过孟德尔随机化方法,在1400种代谢物和前列腺炎中鉴定出谷氨酰胺/前列腺炎环路的负反馈

Wang, Yi; Ji, Hao; Chen, Yingfei; Zhu, Bingye; Peng, Yongming; Xing, Qianwei

FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.

通过单细胞和批量 RNA 测序,FOXM1 可以作为桥梁,介导透明细胞肾细胞癌的预后和免疫

Zhou Jianhua, Xu Zhuxian, Yu Yang, Zhu Bingye, Xing Qianwei

Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing

单细胞和批量RNA测序结果显示,ADH5表达升高提示肾透明细胞癌(KIRC)预后良好,且与免疫相关。

Sun, Junhao; Zhang, Xinyu; Wu, Fan; Zhu, Bingye; Xie, Huyang

Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing

通过单细胞和批量RNA测序发现,CDC45表达升高预示着肾透明细胞癌患者总体生存预后较差和免疫反应较弱。

Zhang, Xinyu; Zhou, Jianhua; Wang, Yong; Wang, Xing; Zhu, Bingye; Xing, Qianwei

Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity

PTTG1 水平升高预示肾透明细胞癌预后不良,并与免疫相关。

Zhang, Xinyu; Ji, Hao; Huang, Yeqing; Zhu, Bingye; Xing, Qianwei

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

METTL14表达降低预示着透明细胞肾细胞癌预后不良,并可用于构建预后特征。

Wang, Yi; Cong, Rong; Liu, Shouyong; Zhu, Bingye; Wang, Xing; Xing, Qianwei

Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma

肾透明细胞癌小分子药物的鉴定及新型自噬相关预后特征的开发

Xing, Qianwei; Ji, Chengjian; Zhu, Bingye; Cong, Rong; Wang, Yi

MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5

miR-455-5p通过靶向CCR5抑制前列腺癌的进展

Xing, Qianwei; Xie, Huyang; Zhu, Bingye; Sun, Zhiwei; Huang, Yeqing